Sterile IV Containers Market Report 2026

Sterile IV Containers Market Overview

• Sterile IV Containers market size has reached to $6.36 billion in 2025 • Expected to grow to $10.61 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Increasing Home Healthcare Adoption Drives Growth In The Sterile Intravenous (IV) Containers Market • Market Trend: Pre-Mixed Solutions Reduce Compounding Errors And Contamination • North America was the largest region in 2025.

What Is Covered Under Sterile IV Containers Market?

Sterile intravenous (IV) containers refer to medical-grade containers designed to hold intravenous (IV) fluids and medications that are administered directly into a patient’s bloodstream. These containers are sterilized to ensure that they are free from any contaminants, such as bacteria or other pathogens, which could cause infections when the contents are infused into the body. The main types of sterile IV containers are pour bottles and flexible bags. Pour bottles are sterile intravenous (IV) containers with a rigid structure designed to allow controlled dispensing of fluids, making them ideal for use in hospitals and clinics where precise delivery of intravenous solutions is required. They are made from materials such as non-polyvinyl chloride (PVC) and polyvinyl chloride (PVC) and are used in various applications, such as hospitals, clinics, ambulatory care centers, and others.

What Is The Sterile IV Containers Market Growth Forecast?

The sterile iv containers market size is expected to see rapid growth in the next few years. It will grow to $10.61 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to ambulatory care growth, sustainability initiatives, iv drug administration demand, chronic disease treatment, healthcare infrastructure expansion. Major trends in the forecast period include rising demand for non pvc iv containers, growth of pre filled iv solutions, increased focus on infection prevention, expansion of hospital and clinic infrastructure, adoption of customizable iv packaging.

Global Sterile IV Containers Market Segmentation

1) By Type: Pour Bottles, Flexible Bags 2) By Material: Non-Polyvinyl Chloride (PVC), Polyvinyl Chloride (PVC) 3) By Application: Hospital, Clinic, Ambulatory Care Centers, Other Applications Subsegments: 1) By Pour Bottles: Glass Pour Bottles, Plastic Pour Bottles, Single-Dose Pour Bottles, Multi-Dose Pour Bottles 2) By Flexible Bags: Polyvinyl Chloride (PVC) Bags, Polyolefin Bags, Non-PVC Flexible Bags, Customizable IV Bags For Specific Solutions, Pre-Filled Flexible Bags

What Is The Driver Of The Sterile IV Containers Market?

The increasing adoption of home healthcare is expected to propel the growth of the sterile IV containers market going forward. Home healthcare involves providing medical and personal care services to patients in their own homes, allowing them to receive treatment and support outside of traditional healthcare facilities. The rising adoption of home healthcare is largely driven by the growing elderly population, as they increasingly require long-term intravenous therapies and chronic disease management at home. Sterile IV containers are increasingly used in home healthcare to ensure safe and infection-free administration of intravenous therapies. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, spending on services from freestanding home health care agencies increased by 10.8% in 2023, to $147.8 billion, representing a 6.7% increase from 2022. Therefore, the increasing adoption of home healthcare is driving the sterile IV containers industry.

Key Players In The Global Sterile IV Containers Market

Major companies operating in the sterile iv containers market are Cardinal Health Inc., Fresenius Kabi, Medline Industries Inc., Becton Dickinson and Company BD, Baxter International Inc., B Braun SE, Terumo Medical Corporation, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Amsino International Inc., Technoflex, MedicoPack, JW Life Science Corp, SSY Group Limited, Vioser SA, Polycine GmbH, Grifols SA, EuroLife Healthcare Pvt Ltd, Huaren Pharmaceutical Co Ltd, Sichuan Kelun Pharmaceutical Co Ltd, IVEN Pharmatech, Nephron Pharmaceuticals

Global Sterile IV Containers Market Trends and Insights

Major companies operating in the sterile IV container market are focusing on developing advanced drug delivery systems, such as pre-mixed solutions in duplex containers, to boost efficiency, enhance medication safety, and reduce manual compounding errors and contamination risks. Pre-mixed solutions in duplex containers refer to integrated drug delivery systems where a medication is pre-mixed in a flexible plastic container, requiring only the activation of a single connector to be ready for intravenous administration. For instance, in March 2025, B. Braun Medical Inc., a US-based medical device company, launched Ready-to-Activate Cefazolin 3 gram pre-mix in Duplex containers. The Duplex system is a dual-chamber container that maintains separation between the drug powder and the diluent until the point of use. It includes a ready-to-activate design, enabling healthcare professionals to quickly mix the solution by simply manipulating the container, which eliminates the need for complex manual reconstitution and reduces the potential for contamination and dosing errors.

What Are Latest Mergers And Acquisitions In The Sterile IV Containers Market?

In November 2024, ICU Medical Inc., a US-based medical device company, and Otsuka Pharmaceutical Factory Inc. formed a joint venture to strengthen IV solutions manufacturing and innovation in North America. This joint venture combines ICU Medical’s infusion device expertise with Otsuka’s pharmaceutical capabilities to boost IV solution production and improve patient care. Otsuka Pharmaceutical Factory Inc. is a Japan-based pharmaceutical company specializing in sterile IV containers and injectable drug solutions.

Regional Outlook

North America was the largest region in the sterile IV containers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Sterile IV Containers Market?

The sterile IV containers market consists of sales of sterile intravenous (IV) bags, pre-filled containers, y-site connectors, and needle-free valves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.